CN109562077A - 组合物和治疗方法 - Google Patents

组合物和治疗方法 Download PDF

Info

Publication number
CN109562077A
CN109562077A CN201780019759.6A CN201780019759A CN109562077A CN 109562077 A CN109562077 A CN 109562077A CN 201780019759 A CN201780019759 A CN 201780019759A CN 109562077 A CN109562077 A CN 109562077A
Authority
CN
China
Prior art keywords
composition
terbinafine
nail
salt
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780019759.6A
Other languages
English (en)
Chinese (zh)
Inventor
约翰·瑞登
克里斯廷·卡罗琳·瑞登
大卫·库克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Blueberry Therapeutics Ltd
Original Assignee
Blueberry Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blueberry Therapeutics Ltd filed Critical Blueberry Therapeutics Ltd
Priority to CN202311073155.3A priority Critical patent/CN117379391A/zh
Publication of CN109562077A publication Critical patent/CN109562077A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Optics & Photonics (AREA)
  • Emergency Medicine (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CN201780019759.6A 2016-03-25 2017-03-24 组合物和治疗方法 Pending CN109562077A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202311073155.3A CN117379391A (zh) 2016-03-25 2017-03-24 组合物和治疗方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1605127.8A GB201605127D0 (en) 2016-03-25 2016-03-25 Composition and methods of treatment
GB1605127.8 2016-03-25
PCT/GB2017/050852 WO2017163091A1 (en) 2016-03-25 2017-03-24 Composition and methods of treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202311073155.3A Division CN117379391A (zh) 2016-03-25 2017-03-24 组合物和治疗方法

Publications (1)

Publication Number Publication Date
CN109562077A true CN109562077A (zh) 2019-04-02

Family

ID=56027421

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201780019759.6A Pending CN109562077A (zh) 2016-03-25 2017-03-24 组合物和治疗方法
CN202311073155.3A Pending CN117379391A (zh) 2016-03-25 2017-03-24 组合物和治疗方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202311073155.3A Pending CN117379391A (zh) 2016-03-25 2017-03-24 组合物和治疗方法

Country Status (6)

Country Link
US (1) US20200206160A1 (enExample)
EP (1) EP3432867A1 (enExample)
JP (2) JP2019509281A (enExample)
CN (2) CN109562077A (enExample)
GB (1) GB201605127D0 (enExample)
WO (1) WO2017163091A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111629717A (zh) * 2017-06-30 2020-09-04 蓝莓疗法有限公司 由聚合物和特比萘芬形成的纳米颗粒

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4041839A4 (en) 2019-10-08 2023-10-11 Hallux, Inc. ONYCHOMYCOSIS TREATMENT COMPOSITIONS AND METHODS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103429246A (zh) * 2010-12-29 2013-12-04 战略科学与技术有限责任公司 真菌感染和其它适应症的治疗的透皮递送
WO2015044669A1 (en) * 2013-09-25 2015-04-02 Blueberry Therapeutics Limited Antifungal topical composition and methods of treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030147925A1 (en) * 1998-09-11 2003-08-07 Samuel P. Sawan Topical dermal antimicrobial compositions, methods for generating same, and monitoring methods utilizing same
WO2011079234A2 (en) * 2009-12-23 2011-06-30 Nuvo Research Inc. Highly permeating terbinafine formulation
EP2664327A1 (en) * 2012-05-14 2013-11-20 Almirall S.A. Topical pharmaceutical compositions comprising terbinafide and urea
US8697753B1 (en) * 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
GB201511799D0 (en) 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103429246A (zh) * 2010-12-29 2013-12-04 战略科学与技术有限责任公司 真菌感染和其它适应症的治疗的透皮递送
WO2015044669A1 (en) * 2013-09-25 2015-04-02 Blueberry Therapeutics Limited Antifungal topical composition and methods of treatment

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111629717A (zh) * 2017-06-30 2020-09-04 蓝莓疗法有限公司 由聚合物和特比萘芬形成的纳米颗粒

Also Published As

Publication number Publication date
JP2019509281A (ja) 2019-04-04
CN117379391A (zh) 2024-01-12
US20200206160A1 (en) 2020-07-02
WO2017163091A1 (en) 2017-09-28
JP2023182607A (ja) 2023-12-26
GB201605127D0 (en) 2016-05-11
EP3432867A1 (en) 2019-01-30

Similar Documents

Publication Publication Date Title
JP7028836B2 (ja) 抗真菌局所組成物および処置の方法
Bhowmik Recent advances in novel topical drug delivery system
JP7320559B2 (ja) 組成物および治療方法
JP2023182607A (ja) 組成物および治療方法
JP2007534764A (ja) 抗真菌薬物送達
Musa et al. Novel topical nano-colloidal carrier loaded with cyclosporine: Biological evaluation potentially for psoriasis treatment
JP2025000870A (ja) ポリマー及びテルビナフィンから形成されるナノ粒子
Kinski et al. Evaluation of the permeation and penetration of two formulations of terbinafine chlorhydrate incorporated in liposomes (cream 1%) vs. a Conventional Formulation (Cream 1%), in an in Vitro-ex Vivo Model
CN108348456A (zh) 异维甲酸制剂及其用途和方法
Yadav et al. Exploring the Potential of Topical Drug Delivery System: A Systematic Review
Sharma et al. Dermatological preparations, formulation and evaluation of various semi-solid dosage form
Detroja et al. Development and Evaluation of Ketoconazole Serum
RU2469706C2 (ru) Фармацевтическая композиция для трансдермального применения для увеличения активности лекарственных веществ и снижения их побочных эффектов
Morales Mucoadhesive films for the buccal delivery of insulin
Adam et al. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
WO2007064181A1 (es) Preparaciones para el cuidado de las uñas que contienen clorhidrato de terbinafina

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190402

RJ01 Rejection of invention patent application after publication